Resources
About Us
Meticulous Research®—a leading global market research company, published a research report titled, ‘Europe Point-of-Care Diagnostics Market by Application (Influenza, Pneumonia, TB, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker, Urinalysis), Platform (LFA, Molecular), Sample, and End User - Forecast to 2030.'
According to this latest publication from Meticulous Research®, the Europe point-of-care diagnostics market is expected to register a CAGR of 4.1% from 2024 to reach $12.98 billion by 2030. The increasing prevalence of infectious and chronic diseases, rising adoption of technical advancements to enhance the quality of point-of-care diagnostics, development of CLIA-waived PoC tests, and a growing number of in-house hospital laboratories opting for PoC diagnostics are the key factors driving the Europe point of care diagnostics market. In addition, healthcare professionals’ increasing preference for POC tests over other lab tests and growing advanced healthcare infrastructure across European countries are expected to offer significant growth opportunities in the market. However, limited reimbursement policies and cost constraints are expected to restrain the growth of this market to some extent.
Key Players:
The key players operating in the Europe point-of-care diagnostics market are Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), bioMérieux S.A. (France), QuidelOrtho Corporation (U.S.), Sekisui Diagnostics, LLC. (U.S.), Chembio Diagnostics, Inc. (U.S.), EKF Diagnostics Holdings plc (U.K.), Trinity Biotech plc (Ireland), Werfen (Spain), and Nova Biomedical (U.S.).
Europe Point-of-Care Diagnostics Market: Future Outlook
The Europe point-of-care diagnostics market is segmented by offering (consumables, instruments, and software and services); platform (lateral flow assays, molecular diagnostics, and other platform); application (blood glucose monitoring, infectious disease testing [parasitic infections testing, blood-borne infections testing {Hepatitis, HIV, other blood-borne infections}, respiratory infections testing {Influenza, Pneumonia, COVID-19 testing, other respiratory infections testing}, healthcare-associated infection (HAI) testing, gastrointestinal infections testing {salmonellosis, E. Coli infections, other GI infections} other infectious diseases testing], tumor/cancer markers testing, pregnancy and fertility testing [pregnancy testing, fertility testing], cardiac marker/cardiac metabolism testing, cholesterol/lipid profile testing, coagulation testing [prothrombin time (PT/INR) testing, activated clotting time (ACT/APTT) testing, other coagulation testing], hematology, drugs of abuse testing, urinalysis, other POC testing); sample type (blood sample, nasopharyngeal swab, urine sample, saliva sample, other sample types); end user (home care/self-testing, hospitals, physician offices & ambulatory care settings, diagnostics laboratories, and other end users), and geography. The study also evaluates industry competitors and analyzes their market share at the country level.
Among all the offerings in the report, the consumables segment is expected to account for the largest share of the point-of-care diagnostics market. Factors such as Recurrent use of consumables in the detection of various diseases through diagnostics, rise in product approvals, increased use of kits in healthcare settings, and technological advancements in ELISpot assay kits, direct-to-customer tests contribute to the large share of the kits & reagents segment.
Among all the platforms studied in the report, the molecular diagnostics segment is projected to grow fastest during the forecast period. The growing need for advanced diagnostic techniques, the widening applications of molecular detection tests in various fields, and product launches are the major factors contributing to the market's growth.
Among all the applications studied in the report, in 2024, the blood glucose monitoring segment is expected to account for the largest share of the Europe point-of-care diagnostics market. The large market share of this segment is attributed to the rising prevalence of diabetes, new product launches, and the growing need for blood glucose monitoring. The major factors responsible for such a high incidence of diabetes are the lack of awareness and knowledge, physical inactivity, and the growing prevalence of obesity. Therefore, it is important to periodically monitor the blood glucose level to prevent further implications of diabetes.
Among all the sample types studied in the report, the blood sample type segment is expected to account for the highest CAGR during the forecast period. The growth of this segment is attributed to the availability of a large variety of tests using blood samples, increasing prevalence of various chronic diseases, and increasing consumer awareness regarding the monitoring of chronic diseases.
Among all the end users studied in the report, the hospital segment is expected to account for the largest share of the Europe point-of-care diagnostics market in 2024. As hospitals perform various tests to diagnose various medical conditions, the increasing healthcare expenditure worldwide is expected to boost the point-of-care diagnostics market. Point-of-care (PoC) devices are widely used in various areas of the hospital, including the emergency department (ED), intensive care unit (ICU), operating room/reanimation, delivery room/neonatal ward, CT scanning/invasive radiology, diabetic care ward, and dialysis unit. PoC testing is particularly prevalent in the ED, as it enables rapid confirmation of diagnoses, allowing for quick treatment initiation and reducing patient wait times.
Among all the countries studied in the report, Germany is expected to account for the largest share of the European point-of-care diagnostics market in 2024. The large market share of Germany is attributed to the rising prevalence of infectious diseases, the rising number of deaths associated with behavioral risk factors, and the growth in the country’s aging population with a high incidence of chronic diseases are driving the growth of this market.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5650
Key questions answered in the report:
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
India VNA & PACS Market to Reach $341.6 Million by 2031
Read MoreChina Microarray Market to Be Worth $910.4 Million by 2031
Read MoreChina Neurogenomics Market to Reach $562.1 Million by 2031
Read MoreELISA Market to be Worth $32.69 Billion by 2031
Read MoreDNA Sequencing Market to be Worth $21.30 Billion by 2031
Read MoreOral Care Market to be Worth $58.99 Billion by 2031
Read MoreSpirometer Market to be Worth $1.80 Billion by 2031
Read MorePet Care Market to be Worth $287.96 Billion by 2031
Read MoreRegenerative Medicine Market to be Worth $37.27 Billion by 2031
Read MoreHemostats Market to be Worth $5.32 Billion by 2031
Read MoreBioreactors Market to be Worth $39.96 Billion by 2031
Read MoreProtein Assays Market to be Worth $4.36 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreAsia-Pacific NGS Automation Market to be Worth $371 Million by 2031
Read MoreLatin America NGS Market to be Worth $765.2 Million by 2031
Read MoreBiochemical Reagents Market to be Worth $39.61 Billion by 2031
Read MoreMicroarray Kits Market to be Worth $2.51 Billion by 2031
Read MoreAntibody Production Market to Reach $58.35 Billion by 2031
Read MoreMiddle East IVD Market to be Worth $2.15 Billion by 2031
Read MoreSpatial Genomics Market to be Worth $3.23 Billion by 2031
Read MoreAsia-Pacific IVD Market to be Worth $36.02 Billion by 2031
Read MoreEurope NGS Market to be Worth $6.40 Billion by 2030
Read MoreLab Automation Market to be Worth $11.31 Billion by 2031
Read MoreBioinformatics Market to Reach $31.71 Billion by 2031
Read MoreEurope IVD Market to be Worth $39.77 Billion by 2030
Read MoreSequencing Kits Market to be Worth $25.29 Billion by 2031
Read MoreVeterinary API Market to Reach $15.84 Billion by 2031
Read MoreSample Preparation Market to be Worth $12.77 Billion by 2031
Read MoreSurgical Robots Market Worth $25.47 Billion by 2030
Read MoreMedical Coatings Market Worth $3.32 Billion by 2030
Read MoreLiquid Handling Systems Market Worth $6.99 Billion by 2029
Read MoreElectrosurgery Market to be Worth $8.99 Billion by 2031
Read MoreRadiation Dose Management Market Worth $749.1 Million by 2029
Read MoreMolecular Diagnostics Market Worth $46.69 Billion by 2030
Read MoreNewborn Screening Market to be Worth $2.69 Billion by 2031
Read MorePharmacogenomics Market to be Worth $19.5 Billion by 2031
Read MoreDental Practice Management Software Market Worth $ 3.11 Billion by 2029
Read MoreNepal IVD Market Worth $62.7 Million by 2029
Read MorePharmaceutical Contract Packaging Market Worth $42.03 Billion by 2029
Read MoreIndonesia IVD Market Worth $1.11 Billion by 2029
Read MoreMedical Waste Management Market Worth $17.02 billion by 2030
Read MoreEmpty Capsules Market Worth $4.47 Billion by 2029
Read MoreClear Aligners Market to be worth $18.8 Billion by 2030
Read MoreHLA Typing Market Worth $1.9 Billion by 2029
Read MoreReal-world Data Market Worth $1.66 billion by 2029
Read MoreTrack and Trace Solutions Market Worth $27.27 billion by 2029
Read MoreSurface Disinfectant Market Worth $9.52 Billion by 2029
Read MoreElectronic Lab Notebook Market Worth $787.7 million by 2029
Read MoreRapid Diagnostics Market to be Worth $22.65 Billion By 2031
Read MorePlasma Therapy Market Worth $882.5 Million by 2028
Read MorePeripheral Vascular Devices Market Worth $12.02 Billion by 2028
Read MoreBiomaterials Market to Reach 128.7 Billion USD by 2023
Read MoreVaccine Storage Equipment Market Worth $1.83 billion by 2027
Read MorePlasma Fractionation Market Worth $46.9 Billion by 2029
Read MoreHome Healthcare Market to be Worth $514.5 Billion by 2030
Read MoreCardiac Pacemaker Devices Market Worth $4.34 Billion by 2028
Read MoreEuropean Laboratory Informatics Market Worth $1,084.3 Million By 2024
Read MoreCompetent Cells Market Worth 2,318.6 Million USD By 2023
Read MoreCancer Immunotherapy Market to be Worth $267.2 Billion by 2030
Read MoreMultimodal Imaging Market Worth $1.6 Billion By 2024
Read MorePulse Lavage Market to be Worth $661.1 Million by 2030
Read MoreMedical Cooling Systems Market Worth $2.8 Billion By 2024
Read MoreTissue Diagnostics Market Worth $8.52 Billion by 2029
Read MoreEndoscopy Equipment Market Worth $59.8 Billion by 2029
Read MoreAfrican Forensic DNA Testing Market Worth $136.3 Million by 2025
Read MoreClinical Trial Supplies Market to be Worth $5.59 Billion by 2031
Read MoreInfection Control Market Worth $58.2 Billion by 2027
Read MoreSleep Apnea Devices Market Worth $12.9 billion by 2027
Read MoreMedical 3D Printing Market To Reach $983.2 Million By 2020
Read MoreGenomics Market to be Worth $70.52 Billion by 2031
Read MoreAnalytical Standards Market Worth $2.66 Billion By 2027
Read MoreTelehealth Market Worth $539.73 Billion by 2029
Read MoreCell Culture Market Worth $48.63 Billion by 2029
Read MoreAntimicrobial Coatings Market to be Worth $12.41 Billion by 2031
Read MoreFlow Cytometry Market Worth $6.4 Billion by 2027
Read MoreMedical Aesthetics Market Worth $29.43 billion by 2029
Read MoreOligonucleotide Synthesis Market Worth $3.9 Billion by 2025
Read MoreIn Vitro Diagnostics Market to be Worth $116.28 Billion by 2031
Read MoreDental Implants Market Worth $6.52 Billion by 2029
Read MoreActive Implantable Devices Market Worth 24.02 Billion USD By 2022
Read MoreVentilators Market to be Worth $13.23 Billion by 2031
Read MoreDialysis Market to be Worth $36.6 Billion by 2031
Read MorePlasmapheresis Market to be Worth $2.55 Billion by 2030
Read MoreDiabetes Care Devices Market Worth $31.9 Billion by 2028
Read MoreClinical Genomics Market Worth 879.0 Million USD By 2023
Read MoreIVD Quality Control Market to be Worth $2.28 Billion by 2031
Read MoreLaboratory Informatics Market Worth $6.1 Billion by 2030
Read MoreChromatography Data Systems Market to be Worth $1.7 billion by 2030
Read MoreBone Growth Stimulators Market Worth $1.94 Billion by 2030
Read MoreDigital Diabetes Market worth $12.03 billion by 2025
Read MoreTrocars Market Worth $968.5 Million by 2024
Read MoreHealthcare Virtual Assistant Market Worth $1.76 Billion By 2025
Read MoreEurope Hospital Beds Market to be Worth $2.09 Billion by 2030
Read MoreImmunoassay Market Worth $46.49 Billion by 2028
Read MoreHospital Beds Market Worth $ 6.66 Billion by 2030
Read MoreUrinalysis Market Worth $2.19 billion by 2027
Read MoreMedical Image Management Market Worth $7.22 billion by 2030
Read MoreBreast Imaging Market Worth $7.08 Billion by 2027
Read MoreVNA & PACS Market to be Worth $6.50 Billion by 2031
Read More